Abstract
Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Current Bioactive Compounds
Title: Bone Modulating Bioactive Natural Compounds: Review
Volume: 3 Issue: 3
Author(s): Kanji Mori, Dominique Heymann and Ronan Le Bot
Affiliation:
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Abstract: Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Export Options
About this article
Cite this article as:
Mori Kanji, Heymann Dominique and Bot Le Ronan, Bone Modulating Bioactive Natural Compounds: Review, Current Bioactive Compounds 2007; 3 (3) . https://dx.doi.org/10.2174/157340707781695613
DOI https://dx.doi.org/10.2174/157340707781695613 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study
Current Pharmaceutical Biotechnology An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Medicinal Chemistry Reviews - Online (Discontinued) Dietary Phytoestrogens: Neuroprotective Role in Parkinson’s Disease
Current Neurovascular Research Role of Unani Medicines in Cancer Control and Management
Current Drug Therapy N6-methyladenine RNA Modification (m<sup>6</sup>A): An Emerging Regulator of Metabolic Diseases
Current Drug Targets The Role of hsa-miR-548l Dysregulation as a Putative Modifier Factor for Glaucoma-Associated FOXC1 Mutations
MicroRNA Biotransformations of Prenylated Hop Flavonoids for Drug Discovery and Production
Current Drug Metabolism The Complex Biology of FOXO
Current Drug Targets E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Current Pharmaceutical Biotechnology Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines <i>In Vitro</i> Study
Current Pharmaceutical Biotechnology Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Epigenetic Modification Restores Functional PR Expression in Endometrial Cancer Cells
Current Pharmaceutical Design Pioglitazone and Cancer: Angel or Demon?
Current Pharmaceutical Design Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?
Current Cancer Drug Targets Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges
Current Vascular Pharmacology Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer
Current Cancer Drug Targets Dietary Phytochemicals in Chemoprevention of Cancer: An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)